Amfetamiini (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amfetamiini" in Finnish language version.

Last modified: 22:05:00, 31 July 2025 (UTC)

Ref.Un. Ref.Website

Global rank Finnish rank

9759nih.gov

5^th place

13^th place

7737doi.org

2^nd place

11^th place

5836worldcat.org

4^th place

9^th place

91europa.eu

62^nd place

41^st place

62researchgate.net

96^th place

195^th place

54web.archive.org

1^st place

53urn.fi

4,639^th place

180^th place

52paihdelinkki.fi

low place

852^nd place

44sciencedirect.com

137^th place

190^th place

42wiley.com

150^th place

153^rd place

32finlex.fi

3,087^th place

36^th place

21kaypahoito.fi

low place

365^th place

21duodecimlehti.fi

low place

155^th place

11wada-ama.org

low place

11jamanetwork.com

3,157^th place

1,733^rd place

11sagepub.com

609^th place

782^nd place

11nature.com

207^th place

199^th place

11aspetjournals.org

8,671^st place

5,674^th place

11yle.fi

197^th place

2^nd place

11kultti.net

low place

11julkari.fi

low place

641^st place

11unodc.org

2,954^th place

2,694^th place

aspetjournals.org (Global: 8,671^st place; Finnish: 5,674^th place)

jpet.aspetjournals.org

LD Simmler et al: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 0022-3565 Artikkelin verkkoversio.

doi.org (Global: 2^nd place; Finnish: 11^th place)

dx.doi.org

JS Markowitz, KS Patrick: The clinical pharmacokinetics of amphetamines utilized in the treatment of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 2017, 27. vsk, nro 8, s. 678–689. PubMed:28910145 doi:10.1089/cap.2017.0071 ISSN 1557-8992 Artikkelin verkkoversio.
SL Greene, F Kerr, G Braitberg: Review article: amphetamines and related drugs of abuse. Emergency medicine Australasia, 2008, 20. vsk, nro 5, s. 391–402. PubMed:18973636 doi:10.1111/j.1742-6723.2008.01114.x ISSN 1742-6723 Artikkelin verkkoversio.
DJ Heal et al: Amphetamine, past and present a pharmacological and clinical perspective. Journal of Psychopharmacology, 2013, 27. vsk, nro 6, s. 479–496. PubMed:23539642 doi:10.1177/0269881113482532 ISSN 0269-8811 Artikkelin verkkoversio.
Amphetamine: a European Union perspective in the global context. Publications Office of the European Union, 2011. doi:10.2810/49525 ISBN 9789291684915 Teoksen verkkoversio.
JCM Brust: Neurological aspects of substance abuse, s. 105–115. (2. painos) Elsevier, 2004. doi:10.1016/B978-0-7506-7313-6.50008-8 ISBN 9780750673136
A Sinha et al: Amphetamine abuse related acute myocardial infarction. Case Reports in Cardiology, 2016. PubMed:26998366 doi:10.1155/2016/7967851 ISSN 2090-6404 Artikkelin verkkoversio.
PK Gillman: Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 2005, 95. vsk, nro 4, s. 434–441. PubMed:16051647 doi:10.1093/bja/aei210 ISSN 0007-0912 Artikkelin verkkoversio.
N Rasmussen: America’s first amphetamine epidemic 1929-1971. American Journal of Public Health, 2008, 98. vsk, nro 6, s. 974–985. PubMed:18445805 doi:10.2105/AJPH.2007.110593 ISSN 0090-0036 Artikkelin verkkoversio.
AC Childress et al: The efficacy and safety of evekeo, racemic amphetamine sulfate, for treatment of attention-deficit/hyperactivity disorder symptoms: a multicenter, dose-optimized, double-blind, randomized, placebo-controlled crossover laboratory classroom study. Journal of Child and Adolescent Psychopharmacology, 2015, 25. vsk, nro 5, s. 402–414. PubMed:25692608 doi:10.1089/cap.2014.0176 ISSN 1044-5463 Artikkelin verkkoversio.
OL Gericke: Suicide by ingestion of amphetamine sulfate. Journal of the American Medical Association, 1945, 128. vsk, nro 15, s. 1098–1099. doi:10.1001/jama.1945.92860320004011b ISSN 0002-9955 Artikkelin verkkoversio.
EG Zalis et al: Acute lethality of the amphetamines in dogs and its antagonism by curare. Proceedings of the Society for Experimental Biology and Medicine, 1965, 118. vsk, nro 2, s. 557–561. PubMed:14268681 doi:10.3181/00379727-118-29904 ISSN 0037-9727 Artikkelin verkkoversio.
JF Bowyer, JP Hanig: Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 172–182. PubMed:27626044 doi:10.4161/23328940.2014.982049 ISSN 2332-8940 Artikkelin verkkoversio.
JG Bramness et al: Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry, 2012, 12. vsk, s. 221–228. PubMed:23216941 doi:10.1186/1471-244X-12-221 ISSN 1471-244X Artikkelin verkkoversio.
Z Chang et al: Stimulant ADHD medication and risk for substance abuse. Journal of child psychology and psychiatry, and allied disciplines, 2014, 55. vsk, nro 8, s. 878–885. PubMed:25158998 doi:10.1111/jcpp.12164 ISSN 0021-9630 Artikkelin verkkoversio.
KM Harlé, AJ Yu, MP Paulus: Bayesian computational markers of relapse in methamphetamine dependence. NeuroImage: Clinical, 2019, 22. vsk. PubMed:30928810 doi:10.1016/j.nicl.2019.101794 ISSN 2213-1582 Artikkelin verkkoversio.
M Brecht, D Herbeck: Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug and alcohol dependence, 2014, 139. vsk, s. 18–25. PubMed:24685563 doi:10.1016/j.drugalcdep.2014.02.702 ISSN 0376-8716 Artikkelin verkkoversio.
H Tan et al: History of alcohol and opioid use impacts on the long-term recovery trajectories of methamphetamine-dependent patients. Frontiers in Psychiatry, 2019, 10. vsk. PubMed:31231256 doi:10.3389/fpsyt.2019.00398 ISSN 1664-0640 Artikkelin verkkoversio.
A Sinha et al: Adult ADHD medications and their cardiovascular implications. Case Reports in Cardiology, 2016. PubMed:27579185 doi:10.1155/2016/2343691 ISSN 2090-6404 Artikkelin verkkoversio.
TM Furlong et al: Methamphetamine, d-amphetamine and p-chloroamphetamine induced neurotoxicity differentially effect impulsive responding on the stop-signal task in rats. Neurotoxicity research, 2016, 29. vsk, nro 4, s. 569–582. PubMed:26846719 doi:10.1007/s12640-016-9605-9 ISSN 1029-8428 Artikkelin verkkoversio.
C Ferreira et al: Neuroprotection or neurotoxicity of illicit drugs on Parkinson’s disease. Life, 2020, 10. vsk, nro 6. PubMed:32545328 doi:10.3390/life10060086 ISSN 2075-1729 Artikkelin verkkoversio.
JL Oei et al: Amphetamines, the pregnant woman and her children: a review. Journal of Perinatology, 2012, 32. vsk, nro 10, s. 737–747. PubMed:22652562 doi:10.1038/jp.2012.59 ISSN 1476-5543 Artikkelin verkkoversio.
I Peña, R Gevorkiana, W Shi: Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. European journal of pharmacology, 2015, 764. vsk, s. 562–570. PubMed:26209364 doi:10.1016/j.ejphar.2015.07.044 ISSN 0014-2999 Artikkelin verkkoversio.
K Stemmer et al: CNS-targeting pharmacological interventions for the metabolic syndrome. The Journal of Clinical Investigation, 2019, 129. vsk, nro 10, s. 4058–4071. PubMed:31380808 doi:10.1172/JCI129195 ISSN 0021-9738 Artikkelin verkkoversio.
F Ferrucci et al: The effects of amphetamine and methamphetamine on the release of norepinephrine, dopamine and acetylcholine from the brainstem reticular formation. Frontiers in Neuroanatomy, 2019, 13. vsk. PubMed:31133823 doi:10.3389/fnana.2019.00048 ISSN 1662-5129 Artikkelin verkkoversio.
DD Han, HH Gu: Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology, 2006, 6. vsk, s. 6–13. PubMed:16515684 doi:10.1186/1471-2210-6-6 ISSN 1471-2210 Artikkelin verkkoversio.
PS Hasenhuetl et al: A kinetic account for amphetamine-induced monoamine release. The Journal of General Physiology, 2018, 150. vsk, nro 3, s. 431–451. PubMed:29439119 doi:10.1085/jgp.201711915 ISSN 0022-1295 Artikkelin verkkoversio.
FP Mayer et al: An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology, 2018, 43. vsk, nro 12, s. 2408–2417. PubMed:29773909 doi:10.1038/s41386-018-0053-5 ISSN 0893-133X Artikkelin verkkoversio.
Z Freyberg et al: Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nature Communications, 2016, 7. vsk, nro 10652. PubMed:26879809 doi:10.1038/ncomms10652 ISSN 2041-1723 Artikkelin verkkoversio.
LD Simmler et al: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 0022-3565 Artikkelin verkkoversio.
J Liu, R Wu, J Li: TAAR1 and psychostimulant addiction. Cellular and Molecular Neurobiology, 2020, 40. vsk, nro 2, s. 229–238. PubMed:31974906 doi:10.1007/s10571-020-00792-8 ISSN 1573-6830 Artikkelin verkkoversio.
IH Ulus, TJ Maher, RJ Wurtman: Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. Biochemical Pharmacology, 2000, 59. vsk, nro 12, s. 1611–1621. PubMed:10799660 doi:10.1016/s0006-2952(00)00306-3 ISSN 0006-2952 Artikkelin verkkoversio.
JB Robinson: Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl. Biochemical Pharmacology, 1985, 34. vsk, nro 23, s. 4105–4108. PubMed:3933519 doi:10.1016/0006-2952(85)90201-1 Artikkelin verkkoversio.
J Kitanaka, N Kitanaka, M Takemura: Modification of monoaminergic activity by MAO inhibitors influences methamphetamine actions. Drug Target Insights, 2006, 1. vsk, s. 19–28. PubMed:21901055 doi:10.1177/117739280600100001 ISSN 1177-3928 Artikkelin verkkoversio.
SE Hadland, S Levy: Objective testing - urine and other drug tests. Child and adolescent psychiatric clinics of North America, 2016, 25. vsk, nro 3, s. 549–565. PubMed:27338974 doi:10.1016/j.chc.2016.02.005 ISSN 1056-4993 Artikkelin verkkoversio.
L Edeleano: Ueber einige derivate der phenylmethacrylsäure und der phenylisobuttersäure. Berichte der deutschen chemischen Gesellschaft, 1887, 20. vsk, nro 1, s. 616–622. doi:10.1002/cber.188702001142 ISSN 1099-0682 Artikkelin verkkoversio.
BA Clement eta l: Toxic amines and alkaloids from Acacia berlandieri. Phytochemistry, 1997, 46. vsk, nro 2, s. 249–254. doi:10.1016/S0031-9422(97)00240-9 ISSN 0031-9422 Artikkelin verkkoversio.
SM Berman et al: Potential adverse effects of amphetamine treatment on brain and behavior: a review. Molecular Psychiatry, 2009, nro 2, s. 123–142. PubMed:18698321 doi:10.1038/mp.2008.90 ISSN 1476-5578 Artikkelin verkkoversio.

duodecimlehti.fi (Global: low place; Finnish: 155^th place)

S Rönkä: Amfetamiinien ja opioidien ongelmakäytön yleisyys Suomessa vuonna 2017. Duodecim, 2020, 136. vsk, nro 8, s. 927–935. Artikkelin verkkoversio.

europa.eu (Global: 62^nd place; Finnish: 41^st place)

emcdda.europa.eu

Amphetamine: a European Union perspective in the global context. Publications Office of the European Union, 2011. doi:10.2810/49525 ISBN 9789291684915 Teoksen verkkoversio.

finlex.fi (Global: 3,087^th place; Finnish: 36^th place)

Valtioneuvoston asetus huumausaineina… 543/2008 finlex.fi. Viitattu 5.12.2020.
Korkeimman oikeuden ennakkopäätökset: KKO:1998:162 finlex.fi. Viitattu 5.12.2020.

jamanetwork.com (Global: 3,157^th place; Finnish: 1,733^rd place)

OL Gericke: Suicide by ingestion of amphetamine sulfate. Journal of the American Medical Association, 1945, 128. vsk, nro 15, s. 1098–1099. doi:10.1001/jama.1945.92860320004011b ISSN 0002-9955 Artikkelin verkkoversio.

julkari.fi (Global: low place; Finnish: 641^st place)

S Rönkä, A Virtanen: Huumetilanne Suomessa 2009, s. 129–130. Terveyden ja Hyvinvoinnin Laitos, 2009. ISBN 9789522451903 Teoksen verkkoversio.

kaypahoito.fi (Global: low place; Finnish: 365^th place)

ADHD (aktiivisuuden ja tarkkaavuuden häiriö) kaypahoito.fi. Viitattu 5.12.2020.

kultti.net (Global: low place; Finnish: low place)

kultti.net : Sisutabletteja kultti.net. Arkistoitu 27.3.2007. Viitattu 30.9.2021.

nature.com (Global: 207^th place; Finnish: 199^th place)

JL Oei et al: Amphetamines, the pregnant woman and her children: a review. Journal of Perinatology, 2012, 32. vsk, nro 10, s. 737–747. PubMed:22652562 doi:10.1038/jp.2012.59 ISSN 1476-5543 Artikkelin verkkoversio.

nih.gov (Global: 5^th place; Finnish: 13^th place)

pubmed.ncbi.nlm.nih.gov

JS Markowitz, KS Patrick: The clinical pharmacokinetics of amphetamines utilized in the treatment of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 2017, 27. vsk, nro 8, s. 678–689. PubMed:28910145 doi:10.1089/cap.2017.0071 ISSN 1557-8992 Artikkelin verkkoversio.
SL Greene, F Kerr, G Braitberg: Review article: amphetamines and related drugs of abuse. Emergency medicine Australasia, 2008, 20. vsk, nro 5, s. 391–402. PubMed:18973636 doi:10.1111/j.1742-6723.2008.01114.x ISSN 1742-6723 Artikkelin verkkoversio.
DJ Heal et al: Amphetamine, past and present a pharmacological and clinical perspective. Journal of Psychopharmacology, 2013, 27. vsk, nro 6, s. 479–496. PubMed:23539642 doi:10.1177/0269881113482532 ISSN 0269-8811 Artikkelin verkkoversio.
A Sinha et al: Amphetamine abuse related acute myocardial infarction. Case Reports in Cardiology, 2016. PubMed:26998366 doi:10.1155/2016/7967851 ISSN 2090-6404 Artikkelin verkkoversio.
PK Gillman: Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 2005, 95. vsk, nro 4, s. 434–441. PubMed:16051647 doi:10.1093/bja/aei210 ISSN 0007-0912 Artikkelin verkkoversio.
N Rasmussen: America’s first amphetamine epidemic 1929-1971. American Journal of Public Health, 2008, 98. vsk, nro 6, s. 974–985. PubMed:18445805 doi:10.2105/AJPH.2007.110593 ISSN 0090-0036 Artikkelin verkkoversio.
AC Childress et al: The efficacy and safety of evekeo, racemic amphetamine sulfate, for treatment of attention-deficit/hyperactivity disorder symptoms: a multicenter, dose-optimized, double-blind, randomized, placebo-controlled crossover laboratory classroom study. Journal of Child and Adolescent Psychopharmacology, 2015, 25. vsk, nro 5, s. 402–414. PubMed:25692608 doi:10.1089/cap.2014.0176 ISSN 1044-5463 Artikkelin verkkoversio.
BM Askew: Hyperpyrexia as a contributory factor in the toxicity of amphetamine to aggregated mice. British Journal of Pharmacology and Chemotherapy, 1962, 19. vsk, nro 2, s. 245–257. PubMed:13965240 ISSN 0366-0826 Artikkelin verkkoversio.
EG Zalis et al: Acute lethality of the amphetamines in dogs and its antagonism by curare. Proceedings of the Society for Experimental Biology and Medicine, 1965, 118. vsk, nro 2, s. 557–561. PubMed:14268681 doi:10.3181/00379727-118-29904 ISSN 0037-9727 Artikkelin verkkoversio.
JF Bowyer, JP Hanig: Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 172–182. PubMed:27626044 doi:10.4161/23328940.2014.982049 ISSN 2332-8940 Artikkelin verkkoversio.
JG Bramness et al: Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry, 2012, 12. vsk, s. 221–228. PubMed:23216941 doi:10.1186/1471-244X-12-221 ISSN 1471-244X Artikkelin verkkoversio.
Z Chang et al: Stimulant ADHD medication and risk for substance abuse. Journal of child psychology and psychiatry, and allied disciplines, 2014, 55. vsk, nro 8, s. 878–885. PubMed:25158998 doi:10.1111/jcpp.12164 ISSN 0021-9630 Artikkelin verkkoversio.
KM Harlé, AJ Yu, MP Paulus: Bayesian computational markers of relapse in methamphetamine dependence. NeuroImage: Clinical, 2019, 22. vsk. PubMed:30928810 doi:10.1016/j.nicl.2019.101794 ISSN 2213-1582 Artikkelin verkkoversio.
M Brecht, D Herbeck: Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug and alcohol dependence, 2014, 139. vsk, s. 18–25. PubMed:24685563 doi:10.1016/j.drugalcdep.2014.02.702 ISSN 0376-8716 Artikkelin verkkoversio.
H Tan et al: History of alcohol and opioid use impacts on the long-term recovery trajectories of methamphetamine-dependent patients. Frontiers in Psychiatry, 2019, 10. vsk. PubMed:31231256 doi:10.3389/fpsyt.2019.00398 ISSN 1664-0640 Artikkelin verkkoversio.
A Sinha et al: Adult ADHD medications and their cardiovascular implications. Case Reports in Cardiology, 2016. PubMed:27579185 doi:10.1155/2016/2343691 ISSN 2090-6404 Artikkelin verkkoversio.
TM Furlong et al: Methamphetamine, d-amphetamine and p-chloroamphetamine induced neurotoxicity differentially effect impulsive responding on the stop-signal task in rats. Neurotoxicity research, 2016, 29. vsk, nro 4, s. 569–582. PubMed:26846719 doi:10.1007/s12640-016-9605-9 ISSN 1029-8428 Artikkelin verkkoversio.
C Ferreira et al: Neuroprotection or neurotoxicity of illicit drugs on Parkinson’s disease. Life, 2020, 10. vsk, nro 6. PubMed:32545328 doi:10.3390/life10060086 ISSN 2075-1729 Artikkelin verkkoversio.
JL Oei et al: Amphetamines, the pregnant woman and her children: a review. Journal of Perinatology, 2012, 32. vsk, nro 10, s. 737–747. PubMed:22652562 doi:10.1038/jp.2012.59 ISSN 1476-5543 Artikkelin verkkoversio.
I Peña, R Gevorkiana, W Shi: Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. European journal of pharmacology, 2015, 764. vsk, s. 562–570. PubMed:26209364 doi:10.1016/j.ejphar.2015.07.044 ISSN 0014-2999 Artikkelin verkkoversio.
K Stemmer et al: CNS-targeting pharmacological interventions for the metabolic syndrome. The Journal of Clinical Investigation, 2019, 129. vsk, nro 10, s. 4058–4071. PubMed:31380808 doi:10.1172/JCI129195 ISSN 0021-9738 Artikkelin verkkoversio.
F Ferrucci et al: The effects of amphetamine and methamphetamine on the release of norepinephrine, dopamine and acetylcholine from the brainstem reticular formation. Frontiers in Neuroanatomy, 2019, 13. vsk. PubMed:31133823 doi:10.3389/fnana.2019.00048 ISSN 1662-5129 Artikkelin verkkoversio.
DD Han, HH Gu: Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology, 2006, 6. vsk, s. 6–13. PubMed:16515684 doi:10.1186/1471-2210-6-6 ISSN 1471-2210 Artikkelin verkkoversio.
PS Hasenhuetl et al: A kinetic account for amphetamine-induced monoamine release. The Journal of General Physiology, 2018, 150. vsk, nro 3, s. 431–451. PubMed:29439119 doi:10.1085/jgp.201711915 ISSN 0022-1295 Artikkelin verkkoversio.
FP Mayer et al: An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology, 2018, 43. vsk, nro 12, s. 2408–2417. PubMed:29773909 doi:10.1038/s41386-018-0053-5 ISSN 0893-133X Artikkelin verkkoversio.
Z Freyberg et al: Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nature Communications, 2016, 7. vsk, nro 10652. PubMed:26879809 doi:10.1038/ncomms10652 ISSN 2041-1723 Artikkelin verkkoversio.
LD Simmler et al: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 0022-3565 Artikkelin verkkoversio.
J Liu, R Wu, J Li: TAAR1 and psychostimulant addiction. Cellular and Molecular Neurobiology, 2020, 40. vsk, nro 2, s. 229–238. PubMed:31974906 doi:10.1007/s10571-020-00792-8 ISSN 1573-6830 Artikkelin verkkoversio.
IH Ulus, TJ Maher, RJ Wurtman: Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. Biochemical Pharmacology, 2000, 59. vsk, nro 12, s. 1611–1621. PubMed:10799660 doi:10.1016/s0006-2952(00)00306-3 ISSN 0006-2952 Artikkelin verkkoversio.
JB Robinson: Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl. Biochemical Pharmacology, 1985, 34. vsk, nro 23, s. 4105–4108. PubMed:3933519 doi:10.1016/0006-2952(85)90201-1 Artikkelin verkkoversio.
J Kitanaka, N Kitanaka, M Takemura: Modification of monoaminergic activity by MAO inhibitors influences methamphetamine actions. Drug Target Insights, 2006, 1. vsk, s. 19–28. PubMed:21901055 doi:10.1177/117739280600100001 ISSN 1177-3928 Artikkelin verkkoversio.
SE Hadland, S Levy: Objective testing - urine and other drug tests. Child and adolescent psychiatric clinics of North America, 2016, 25. vsk, nro 3, s. 549–565. PubMed:27338974 doi:10.1016/j.chc.2016.02.005 ISSN 1056-4993 Artikkelin verkkoversio.
SM Berman et al: Potential adverse effects of amphetamine treatment on brain and behavior: a review. Molecular Psychiatry, 2009, nro 2, s. 123–142. PubMed:18698321 doi:10.1038/mp.2008.90 ISSN 1476-5578 Artikkelin verkkoversio.
MP Strohl: Bradley’s benzedrine studies on children with behavioral disorders. The Yale Journal of Biology and Medicine, 2011, 84. vsk, nro 1, s. 27–33. PubMed:21451781 ISSN 0044-0086 Artikkelin verkkoversio.

ncbi.nlm.nih.gov

DJ Heal et al: Amphetamine, past and present a pharmacological and clinical perspective. Journal of Psychopharmacology, 2013, 27. vsk, nro 6, s. 479–496. PubMed:23539642 doi:10.1177/0269881113482532 ISSN 0269-8811 Artikkelin verkkoversio.
A Sinha et al: Amphetamine abuse related acute myocardial infarction. Case Reports in Cardiology, 2016. PubMed:26998366 doi:10.1155/2016/7967851 ISSN 2090-6404 Artikkelin verkkoversio.
N Rasmussen: America’s first amphetamine epidemic 1929-1971. American Journal of Public Health, 2008, 98. vsk, nro 6, s. 974–985. PubMed:18445805 doi:10.2105/AJPH.2007.110593 ISSN 0090-0036 Artikkelin verkkoversio.
AC Childress et al: The efficacy and safety of evekeo, racemic amphetamine sulfate, for treatment of attention-deficit/hyperactivity disorder symptoms: a multicenter, dose-optimized, double-blind, randomized, placebo-controlled crossover laboratory classroom study. Journal of Child and Adolescent Psychopharmacology, 2015, 25. vsk, nro 5, s. 402–414. PubMed:25692608 doi:10.1089/cap.2014.0176 ISSN 1044-5463 Artikkelin verkkoversio.
BM Askew: Hyperpyrexia as a contributory factor in the toxicity of amphetamine to aggregated mice. British Journal of Pharmacology and Chemotherapy, 1962, 19. vsk, nro 2, s. 245–257. PubMed:13965240 ISSN 0366-0826 Artikkelin verkkoversio.
JF Bowyer, JP Hanig: Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 172–182. PubMed:27626044 doi:10.4161/23328940.2014.982049 ISSN 2332-8940 Artikkelin verkkoversio.
JG Bramness et al: Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry, 2012, 12. vsk, s. 221–228. PubMed:23216941 doi:10.1186/1471-244X-12-221 ISSN 1471-244X Artikkelin verkkoversio.
Z Chang et al: Stimulant ADHD medication and risk for substance abuse. Journal of child psychology and psychiatry, and allied disciplines, 2014, 55. vsk, nro 8, s. 878–885. PubMed:25158998 doi:10.1111/jcpp.12164 ISSN 0021-9630 Artikkelin verkkoversio.
KM Harlé, AJ Yu, MP Paulus: Bayesian computational markers of relapse in methamphetamine dependence. NeuroImage: Clinical, 2019, 22. vsk. PubMed:30928810 doi:10.1016/j.nicl.2019.101794 ISSN 2213-1582 Artikkelin verkkoversio.
M Brecht, D Herbeck: Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug and alcohol dependence, 2014, 139. vsk, s. 18–25. PubMed:24685563 doi:10.1016/j.drugalcdep.2014.02.702 ISSN 0376-8716 Artikkelin verkkoversio.
H Tan et al: History of alcohol and opioid use impacts on the long-term recovery trajectories of methamphetamine-dependent patients. Frontiers in Psychiatry, 2019, 10. vsk. PubMed:31231256 doi:10.3389/fpsyt.2019.00398 ISSN 1664-0640 Artikkelin verkkoversio.
A Sinha et al: Adult ADHD medications and their cardiovascular implications. Case Reports in Cardiology, 2016. PubMed:27579185 doi:10.1155/2016/2343691 ISSN 2090-6404 Artikkelin verkkoversio.
TM Furlong et al: Methamphetamine, d-amphetamine and p-chloroamphetamine induced neurotoxicity differentially effect impulsive responding on the stop-signal task in rats. Neurotoxicity research, 2016, 29. vsk, nro 4, s. 569–582. PubMed:26846719 doi:10.1007/s12640-016-9605-9 ISSN 1029-8428 Artikkelin verkkoversio.
C Ferreira et al: Neuroprotection or neurotoxicity of illicit drugs on Parkinson’s disease. Life, 2020, 10. vsk, nro 6. PubMed:32545328 doi:10.3390/life10060086 ISSN 2075-1729 Artikkelin verkkoversio.
I Peña, R Gevorkiana, W Shi: Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. European journal of pharmacology, 2015, 764. vsk, s. 562–570. PubMed:26209364 doi:10.1016/j.ejphar.2015.07.044 ISSN 0014-2999 Artikkelin verkkoversio.
K Stemmer et al: CNS-targeting pharmacological interventions for the metabolic syndrome. The Journal of Clinical Investigation, 2019, 129. vsk, nro 10, s. 4058–4071. PubMed:31380808 doi:10.1172/JCI129195 ISSN 0021-9738 Artikkelin verkkoversio.
F Ferrucci et al: The effects of amphetamine and methamphetamine on the release of norepinephrine, dopamine and acetylcholine from the brainstem reticular formation. Frontiers in Neuroanatomy, 2019, 13. vsk. PubMed:31133823 doi:10.3389/fnana.2019.00048 ISSN 1662-5129 Artikkelin verkkoversio.
DD Han, HH Gu: Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology, 2006, 6. vsk, s. 6–13. PubMed:16515684 doi:10.1186/1471-2210-6-6 ISSN 1471-2210 Artikkelin verkkoversio.
PS Hasenhuetl et al: A kinetic account for amphetamine-induced monoamine release. The Journal of General Physiology, 2018, 150. vsk, nro 3, s. 431–451. PubMed:29439119 doi:10.1085/jgp.201711915 ISSN 0022-1295 Artikkelin verkkoversio.
FP Mayer et al: An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology, 2018, 43. vsk, nro 12, s. 2408–2417. PubMed:29773909 doi:10.1038/s41386-018-0053-5 ISSN 0893-133X Artikkelin verkkoversio.
Z Freyberg et al: Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nature Communications, 2016, 7. vsk, nro 10652. PubMed:26879809 doi:10.1038/ncomms10652 ISSN 2041-1723 Artikkelin verkkoversio.
J Kitanaka, N Kitanaka, M Takemura: Modification of monoaminergic activity by MAO inhibitors influences methamphetamine actions. Drug Target Insights, 2006, 1. vsk, s. 19–28. PubMed:21901055 doi:10.1177/117739280600100001 ISSN 1177-3928 Artikkelin verkkoversio.
SE Hadland, S Levy: Objective testing - urine and other drug tests. Child and adolescent psychiatric clinics of North America, 2016, 25. vsk, nro 3, s. 549–565. PubMed:27338974 doi:10.1016/j.chc.2016.02.005 ISSN 1056-4993 Artikkelin verkkoversio.
SM Berman et al: Potential adverse effects of amphetamine treatment on brain and behavior: a review. Molecular Psychiatry, 2009, nro 2, s. 123–142. PubMed:18698321 doi:10.1038/mp.2008.90 ISSN 1476-5578 Artikkelin verkkoversio.
MP Strohl: Bradley’s benzedrine studies on children with behavioral disorders. The Yale Journal of Biology and Medicine, 2011, 84. vsk, nro 1, s. 27–33. PubMed:21451781 ISSN 0044-0086 Artikkelin verkkoversio.

paihdelinkki.fi (Global: low place; Finnish: 852^nd place)

Amfetamiini paihdelinkki.fi. 22.4.2014. Viitattu 5.12.2020.
Amfetamiini, metamfetamiini sekä muut piristeet paihdelinkki.fi. 13.6.2014. Arkistoitu 1.12.2020. Viitattu 5.12.2020.

researchgate.net (Global: 96^th place; Finnish: 195^th place)

JS Markowitz, KS Patrick: The clinical pharmacokinetics of amphetamines utilized in the treatment of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 2017, 27. vsk, nro 8, s. 678–689. PubMed:28910145 doi:10.1089/cap.2017.0071 ISSN 1557-8992 Artikkelin verkkoversio.
J Liu, R Wu, J Li: TAAR1 and psychostimulant addiction. Cellular and Molecular Neurobiology, 2020, 40. vsk, nro 2, s. 229–238. PubMed:31974906 doi:10.1007/s10571-020-00792-8 ISSN 1573-6830 Artikkelin verkkoversio.

sagepub.com (Global: 609^th place; Finnish: 782^nd place)

journals.sagepub.com

EG Zalis et al: Acute lethality of the amphetamines in dogs and its antagonism by curare. Proceedings of the Society for Experimental Biology and Medicine, 1965, 118. vsk, nro 2, s. 557–561. PubMed:14268681 doi:10.3181/00379727-118-29904 ISSN 0037-9727 Artikkelin verkkoversio.

sciencedirect.com (Global: 137^th place; Finnish: 190^th place)

PK Gillman: Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 2005, 95. vsk, nro 4, s. 434–441. PubMed:16051647 doi:10.1093/bja/aei210 ISSN 0007-0912 Artikkelin verkkoversio.
IH Ulus, TJ Maher, RJ Wurtman: Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. Biochemical Pharmacology, 2000, 59. vsk, nro 12, s. 1611–1621. PubMed:10799660 doi:10.1016/s0006-2952(00)00306-3 ISSN 0006-2952 Artikkelin verkkoversio.
JB Robinson: Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl. Biochemical Pharmacology, 1985, 34. vsk, nro 23, s. 4105–4108. PubMed:3933519 doi:10.1016/0006-2952(85)90201-1 Artikkelin verkkoversio.
BA Clement eta l: Toxic amines and alkaloids from Acacia berlandieri. Phytochemistry, 1997, 46. vsk, nro 2, s. 249–254. doi:10.1016/S0031-9422(97)00240-9 ISSN 0031-9422 Artikkelin verkkoversio.

unodc.org (Global: 2,954^th place; Finnish: 2,694^th place)

Sweden’s successful drug policy: a review of the evidence 2007. United Nations. Arkistoitu 17.5.2020.

urn.fi (Global: 4,639^th place; Finnish: 180^th place)

P Partanen: Amfetamiinien ja opiaattien ongelmakäytön yleisyys Suomessa 2005. Yhteiskuntapolitiikka, 2007, 72. vsk, nro 5, s. 553–561. Artikkelin verkkoversio.
J Ollgren et al: Amfetamiinien ja opioidien ongelmakäytön yleisyys Suomessa 2012. Yhteiskuntapolitiikka, 2014, 74. vsk, nro 5, s. 498–508. Artikkelin verkkoversio.
K Karjalainen, N Pekkanen, P Hakkarainen: Suomalaisten huumeiden käyttö ja huumeasenteet: Huumeaiheiset väestökyselyt Suomessa 1992-2018, s. 57–58. THL, 2020. ISBN 9789523434417 Teoksen verkkoversio.

wada-ama.org (Global: low place; Finnish: low place)

Prohibited list, january 2020 WADA. Viitattu 8.12.2020.

web.archive.org (Global: 1^st place; Finnish: 1^st place)

A Allen, R Ely: Review: synthetic methods for amphetamine web.archive.org. Viitattu 4.12.2020.
kultti.net : Sisutabletteja kultti.net. Arkistoitu 27.3.2007. Viitattu 30.9.2021.
Amfetamiini, metamfetamiini sekä muut piristeet paihdelinkki.fi. 13.6.2014. Arkistoitu 1.12.2020. Viitattu 5.12.2020.
Sweden’s successful drug policy: a review of the evidence 2007. United Nations. Arkistoitu 17.5.2020.

wiley.com (Global: 150^th place; Finnish: 153^rd place)

onlinelibrary.wiley.com

SL Greene, F Kerr, G Braitberg: Review article: amphetamines and related drugs of abuse. Emergency medicine Australasia, 2008, 20. vsk, nro 5, s. 391–402. PubMed:18973636 doi:10.1111/j.1742-6723.2008.01114.x ISSN 1742-6723 Artikkelin verkkoversio.

chemistry-europe.onlinelibrary.wiley.com

L Edeleano: Ueber einige derivate der phenylmethacrylsäure und der phenylisobuttersäure. Berichte der deutschen chemischen Gesellschaft, 1887, 20. vsk, nro 1, s. 616–622. doi:10.1002/cber.188702001142 ISSN 1099-0682 Artikkelin verkkoversio.

worldcat.org (Global: 4^th place; Finnish: 9^th place)

JS Markowitz, KS Patrick: The clinical pharmacokinetics of amphetamines utilized in the treatment of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 2017, 27. vsk, nro 8, s. 678–689. PubMed:28910145 doi:10.1089/cap.2017.0071 ISSN 1557-8992 Artikkelin verkkoversio.
SL Greene, F Kerr, G Braitberg: Review article: amphetamines and related drugs of abuse. Emergency medicine Australasia, 2008, 20. vsk, nro 5, s. 391–402. PubMed:18973636 doi:10.1111/j.1742-6723.2008.01114.x ISSN 1742-6723 Artikkelin verkkoversio.
DJ Heal et al: Amphetamine, past and present a pharmacological and clinical perspective. Journal of Psychopharmacology, 2013, 27. vsk, nro 6, s. 479–496. PubMed:23539642 doi:10.1177/0269881113482532 ISSN 0269-8811 Artikkelin verkkoversio.
A Sinha et al: Amphetamine abuse related acute myocardial infarction. Case Reports in Cardiology, 2016. PubMed:26998366 doi:10.1155/2016/7967851 ISSN 2090-6404 Artikkelin verkkoversio.
PK Gillman: Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 2005, 95. vsk, nro 4, s. 434–441. PubMed:16051647 doi:10.1093/bja/aei210 ISSN 0007-0912 Artikkelin verkkoversio.
N Rasmussen: America’s first amphetamine epidemic 1929-1971. American Journal of Public Health, 2008, 98. vsk, nro 6, s. 974–985. PubMed:18445805 doi:10.2105/AJPH.2007.110593 ISSN 0090-0036 Artikkelin verkkoversio.
AC Childress et al: The efficacy and safety of evekeo, racemic amphetamine sulfate, for treatment of attention-deficit/hyperactivity disorder symptoms: a multicenter, dose-optimized, double-blind, randomized, placebo-controlled crossover laboratory classroom study. Journal of Child and Adolescent Psychopharmacology, 2015, 25. vsk, nro 5, s. 402–414. PubMed:25692608 doi:10.1089/cap.2014.0176 ISSN 1044-5463 Artikkelin verkkoversio.
OL Gericke: Suicide by ingestion of amphetamine sulfate. Journal of the American Medical Association, 1945, 128. vsk, nro 15, s. 1098–1099. doi:10.1001/jama.1945.92860320004011b ISSN 0002-9955 Artikkelin verkkoversio.
BM Askew: Hyperpyrexia as a contributory factor in the toxicity of amphetamine to aggregated mice. British Journal of Pharmacology and Chemotherapy, 1962, 19. vsk, nro 2, s. 245–257. PubMed:13965240 ISSN 0366-0826 Artikkelin verkkoversio.
EG Zalis et al: Acute lethality of the amphetamines in dogs and its antagonism by curare. Proceedings of the Society for Experimental Biology and Medicine, 1965, 118. vsk, nro 2, s. 557–561. PubMed:14268681 doi:10.3181/00379727-118-29904 ISSN 0037-9727 Artikkelin verkkoversio.
JF Bowyer, JP Hanig: Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity. Temperature: Multidisciplinary Biomedical Journal, 2014, 1. vsk, nro 3, s. 172–182. PubMed:27626044 doi:10.4161/23328940.2014.982049 ISSN 2332-8940 Artikkelin verkkoversio.
JG Bramness et al: Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry, 2012, 12. vsk, s. 221–228. PubMed:23216941 doi:10.1186/1471-244X-12-221 ISSN 1471-244X Artikkelin verkkoversio.
Z Chang et al: Stimulant ADHD medication and risk for substance abuse. Journal of child psychology and psychiatry, and allied disciplines, 2014, 55. vsk, nro 8, s. 878–885. PubMed:25158998 doi:10.1111/jcpp.12164 ISSN 0021-9630 Artikkelin verkkoversio.
KM Harlé, AJ Yu, MP Paulus: Bayesian computational markers of relapse in methamphetamine dependence. NeuroImage: Clinical, 2019, 22. vsk. PubMed:30928810 doi:10.1016/j.nicl.2019.101794 ISSN 2213-1582 Artikkelin verkkoversio.
M Brecht, D Herbeck: Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug and alcohol dependence, 2014, 139. vsk, s. 18–25. PubMed:24685563 doi:10.1016/j.drugalcdep.2014.02.702 ISSN 0376-8716 Artikkelin verkkoversio.
H Tan et al: History of alcohol and opioid use impacts on the long-term recovery trajectories of methamphetamine-dependent patients. Frontiers in Psychiatry, 2019, 10. vsk. PubMed:31231256 doi:10.3389/fpsyt.2019.00398 ISSN 1664-0640 Artikkelin verkkoversio.
A Sinha et al: Adult ADHD medications and their cardiovascular implications. Case Reports in Cardiology, 2016. PubMed:27579185 doi:10.1155/2016/2343691 ISSN 2090-6404 Artikkelin verkkoversio.
TM Furlong et al: Methamphetamine, d-amphetamine and p-chloroamphetamine induced neurotoxicity differentially effect impulsive responding on the stop-signal task in rats. Neurotoxicity research, 2016, 29. vsk, nro 4, s. 569–582. PubMed:26846719 doi:10.1007/s12640-016-9605-9 ISSN 1029-8428 Artikkelin verkkoversio.
C Ferreira et al: Neuroprotection or neurotoxicity of illicit drugs on Parkinson’s disease. Life, 2020, 10. vsk, nro 6. PubMed:32545328 doi:10.3390/life10060086 ISSN 2075-1729 Artikkelin verkkoversio.
JL Oei et al: Amphetamines, the pregnant woman and her children: a review. Journal of Perinatology, 2012, 32. vsk, nro 10, s. 737–747. PubMed:22652562 doi:10.1038/jp.2012.59 ISSN 1476-5543 Artikkelin verkkoversio.
I Peña, R Gevorkiana, W Shi: Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. European journal of pharmacology, 2015, 764. vsk, s. 562–570. PubMed:26209364 doi:10.1016/j.ejphar.2015.07.044 ISSN 0014-2999 Artikkelin verkkoversio.
K Stemmer et al: CNS-targeting pharmacological interventions for the metabolic syndrome. The Journal of Clinical Investigation, 2019, 129. vsk, nro 10, s. 4058–4071. PubMed:31380808 doi:10.1172/JCI129195 ISSN 0021-9738 Artikkelin verkkoversio.
F Ferrucci et al: The effects of amphetamine and methamphetamine on the release of norepinephrine, dopamine and acetylcholine from the brainstem reticular formation. Frontiers in Neuroanatomy, 2019, 13. vsk. PubMed:31133823 doi:10.3389/fnana.2019.00048 ISSN 1662-5129 Artikkelin verkkoversio.
DD Han, HH Gu: Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology, 2006, 6. vsk, s. 6–13. PubMed:16515684 doi:10.1186/1471-2210-6-6 ISSN 1471-2210 Artikkelin verkkoversio.
PS Hasenhuetl et al: A kinetic account for amphetamine-induced monoamine release. The Journal of General Physiology, 2018, 150. vsk, nro 3, s. 431–451. PubMed:29439119 doi:10.1085/jgp.201711915 ISSN 0022-1295 Artikkelin verkkoversio.
FP Mayer et al: An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology, 2018, 43. vsk, nro 12, s. 2408–2417. PubMed:29773909 doi:10.1038/s41386-018-0053-5 ISSN 0893-133X Artikkelin verkkoversio.
Z Freyberg et al: Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. Nature Communications, 2016, 7. vsk, nro 10652. PubMed:26879809 doi:10.1038/ncomms10652 ISSN 2041-1723 Artikkelin verkkoversio.
LD Simmler et al: In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. Journal of Pharmacology and Experimental Therapeutics, 2016, 357. vsk, nro 1, s. 134–144. PubMed:26791601 doi:10.1124/jpet.115.229765 ISSN 0022-3565 Artikkelin verkkoversio.
J Liu, R Wu, J Li: TAAR1 and psychostimulant addiction. Cellular and Molecular Neurobiology, 2020, 40. vsk, nro 2, s. 229–238. PubMed:31974906 doi:10.1007/s10571-020-00792-8 ISSN 1573-6830 Artikkelin verkkoversio.
IH Ulus, TJ Maher, RJ Wurtman: Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. Biochemical Pharmacology, 2000, 59. vsk, nro 12, s. 1611–1621. PubMed:10799660 doi:10.1016/s0006-2952(00)00306-3 ISSN 0006-2952 Artikkelin verkkoversio.
J Kitanaka, N Kitanaka, M Takemura: Modification of monoaminergic activity by MAO inhibitors influences methamphetamine actions. Drug Target Insights, 2006, 1. vsk, s. 19–28. PubMed:21901055 doi:10.1177/117739280600100001 ISSN 1177-3928 Artikkelin verkkoversio.
SE Hadland, S Levy: Objective testing - urine and other drug tests. Child and adolescent psychiatric clinics of North America, 2016, 25. vsk, nro 3, s. 549–565. PubMed:27338974 doi:10.1016/j.chc.2016.02.005 ISSN 1056-4993 Artikkelin verkkoversio.
L Edeleano: Ueber einige derivate der phenylmethacrylsäure und der phenylisobuttersäure. Berichte der deutschen chemischen Gesellschaft, 1887, 20. vsk, nro 1, s. 616–622. doi:10.1002/cber.188702001142 ISSN 1099-0682 Artikkelin verkkoversio.
BA Clement eta l: Toxic amines and alkaloids from Acacia berlandieri. Phytochemistry, 1997, 46. vsk, nro 2, s. 249–254. doi:10.1016/S0031-9422(97)00240-9 ISSN 0031-9422 Artikkelin verkkoversio.
SM Berman et al: Potential adverse effects of amphetamine treatment on brain and behavior: a review. Molecular Psychiatry, 2009, nro 2, s. 123–142. PubMed:18698321 doi:10.1038/mp.2008.90 ISSN 1476-5578 Artikkelin verkkoversio.
MP Strohl: Bradley’s benzedrine studies on children with behavioral disorders. The Yale Journal of Biology and Medicine, 2011, 84. vsk, nro 1, s. 27–33. PubMed:21451781 ISSN 0044-0086 Artikkelin verkkoversio.

yle.fi (Global: 197^th place; Finnish: 2^nd place)

Oopiumia yskänlääkkeeksi ja heroiinia kipuun – vielä ehdit nähdä, miten sodan vammoja lääkittiin yle.fi. Viitattu 30.9.2021.

Amfetamiini (Finnish Wikipedia)

aspetjournals.org (Global: 8,671st place; Finnish: 5,674th place)

jpet.aspetjournals.org

doi.org (Global: 2nd place; Finnish: 11th place)

dx.doi.org

duodecimlehti.fi (Global: low place; Finnish: 155th place)

europa.eu (Global: 62nd place; Finnish: 41st place)

emcdda.europa.eu

finlex.fi (Global: 3,087th place; Finnish: 36th place)

jamanetwork.com (Global: 3,157th place; Finnish: 1,733rd place)

julkari.fi (Global: low place; Finnish: 641st place)

kaypahoito.fi (Global: low place; Finnish: 365th place)

kultti.net (Global: low place; Finnish: low place)

nature.com (Global: 207th place; Finnish: 199th place)

nih.gov (Global: 5th place; Finnish: 13th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

paihdelinkki.fi (Global: low place; Finnish: 852nd place)

researchgate.net (Global: 96th place; Finnish: 195th place)

sagepub.com (Global: 609th place; Finnish: 782nd place)

journals.sagepub.com

sciencedirect.com (Global: 137th place; Finnish: 190th place)

unodc.org (Global: 2,954th place; Finnish: 2,694th place)

urn.fi (Global: 4,639th place; Finnish: 180th place)

wada-ama.org (Global: low place; Finnish: low place)

web.archive.org (Global: 1st place; Finnish: 1st place)

wiley.com (Global: 150th place; Finnish: 153rd place)

onlinelibrary.wiley.com

chemistry-europe.onlinelibrary.wiley.com

worldcat.org (Global: 4th place; Finnish: 9th place)

yle.fi (Global: 197th place; Finnish: 2nd place)

aspetjournals.org (Global: 8,671^st place; Finnish: 5,674^th place)

doi.org (Global: 2^nd place; Finnish: 11^th place)

duodecimlehti.fi (Global: low place; Finnish: 155^th place)

europa.eu (Global: 62^nd place; Finnish: 41^st place)

finlex.fi (Global: 3,087^th place; Finnish: 36^th place)

jamanetwork.com (Global: 3,157^th place; Finnish: 1,733^rd place)

julkari.fi (Global: low place; Finnish: 641^st place)

kaypahoito.fi (Global: low place; Finnish: 365^th place)

nature.com (Global: 207^th place; Finnish: 199^th place)

nih.gov (Global: 5^th place; Finnish: 13^th place)

paihdelinkki.fi (Global: low place; Finnish: 852^nd place)

researchgate.net (Global: 96^th place; Finnish: 195^th place)

sagepub.com (Global: 609^th place; Finnish: 782^nd place)

sciencedirect.com (Global: 137^th place; Finnish: 190^th place)

unodc.org (Global: 2,954^th place; Finnish: 2,694^th place)

urn.fi (Global: 4,639^th place; Finnish: 180^th place)

web.archive.org (Global: 1^st place; Finnish: 1^st place)

wiley.com (Global: 150^th place; Finnish: 153^rd place)

worldcat.org (Global: 4^th place; Finnish: 9^th place)

yle.fi (Global: 197^th place; Finnish: 2^nd place)